04:00 PM EST - Victhom Human Bionics Inc. : said its Neurobionix division has obtained CE Mark approval for Neurostep System. The company said it is planning to engage with the U.S. FDA to pursue plans for bringing this new solution for foot drop therapy to patients in the United States. CE Mark represents the regulatory approval needed for the sale of the Neurostep in any of the Member States of the European Union. The company said the CE Mark approval gives the Neurobionix division the ability to train and educate physicians in preparation for market release of the Neurostep System, planned for late 2009 in the European Union. Victhom Human Bionics Inc.
shares T.VHB are trading up $0.01 at $0.03.
